
Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population. It operates as an integrated oncology platform serving patients, providers, and health plans across multiple markets with a focus on delivering high-quality, patient-centered care.
Loading…
Data from Twelve Data. Prices may be delayed.
No analyst coverage available.
Initial Jobless Claims
8:30 AM ET

Bitcoin (BTC)
76,004 +0.39%

Ethereum (ETH)
2,240 +0.19%

Solana (SOL)
90 +0.22%

Corporate PresentationNov 5, 2026
Starling Oncology, Inc. (STLN) is a value-based oncology company dedicated to advancing community cancer care. Founded in 2007, STLN provides cutting-edge, evidence-based treatments, including clinical trials and transfusions, to a large patient population. The company operates an integrated oncology platform, serving patients, providers, and health plans. STLN focuses on delivering high-quality, patient-centered care across multiple markets.
Generated by AI